Market Research Industry Today
Drug Discovery Outsourcing Market to Reach USD 6.24 Billion by 2030, Driven by Rising Oncology and Rare Disease Pipelines
Introduction:
The global drug discovery outsourcing market size stood at USD 4.70 billion in 2025 and is forecast to reach USD 6.24 billion by 2030, registering a 7.35% CAGR during the period. Rising complexities in modern therapies, coupled with the high cost of internal R&D, have made outsourcing a practical strategy to accelerate drug development timelines. By leveraging specialized contract research organizations (CROs), firms can optimize resources across medicinal chemistry, biology, and computational modeling while focusing internal teams on core projects.
Key Trends:
- Rising Burden of Chronic and Rare Diseases
- Escalating Global R&D Spend by Pharma & Biotech Firms
- Cost-Efficiency & Speed-to-Market Imperative
- Proliferation of Virtual / Asset-Light Biotech Start-ups
- Variable Quality Standards Among Mid-Tier Providers
- Stringent Data-Integrity & IP-Protection Requirements
Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights:
Market Segmentation:
By Service Type
- Medicinal Chemistry Services
- Biology Services
- Drug Metabolism and Pharmacokinetics & Toxicology
- Hit-to-Lead & Lead Optimization
- High-Throughput Screening (HTS)
By Drug Type
- Small Molecules
- Large Molecules
- Cell & Gene Therapies
By Therapeutic Area
- Oncology
- Infectious Disease
- Central Nervous System & Neurology
- Respiratory
- Cardiovascular
- Gastrointestinal
- Others
By End-User
- Pharmaceutical Companies
- Biotechnology Companies
- Academic & Research Institutes
By Sourcing Model
- Full-Time Equivalent (FTE)
- Fee-for-Service (FFS)
- Hybrid/Strategic Partnership
Geography Analysis:
North America remains a key hub for drug discovery outsourcing, driven by a concentration of pharmaceutical headquarters, innovative biotechs, and AI-focused startups. U.S. service providers leverage advanced automation, extensive compound libraries, and curated human data, while favorable regulatory frameworks help accelerate project timelines. Canada adds value through government-backed initiatives that support preclinical research.
Explore Our Full Library of Healthcare Research Industry Reports - https://www.mordorintelligence.com/market-analysis/healthcare?utm_source=Industrytoday.co.uk
Key Players:
- Key players in the drug discovery outsourcing market include Charles River Laboratories International, Inc., Thermo Fisher Scientific Inc. (PPD), Laboratory Corporation of America Holdings (Labcorp Drug Development), Eurofins Scientific SE, and WuXi AppTec. These companies are driving innovation and expansion in the sector through advanced research services and comprehensive outsourcing solutions.
Industry Related Reports:
Chronic Obstructive Pulmonary Disease (COPD) Drugs Market - https://www.mordorintelligence.com/industry-reports/chronic-obstructive-pulmonary-disease-drugs-market?utm_source=Industrytoday.co.uk
Autoimmune Treatment Market- https://www.mordorintelligence.com/industry-reports/autoimmune-treatment-market?utm_source=Industrytoday.co.uk
Nuclear Medicine Therapeutics Market - https://www.mordorintelligence.com/industry-reports/nuclear-medicine-therapeutics-market?utm_source=Industrytoday.co.uk
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking actionable market insights. With 550+ domain experts and specialists across 150+ countries, we deliver comprehensive syndicated and custom research across industries such as aerospace, agriculture, chemicals, consumer goods, energy, healthcare, and many more, helping organizations make informed decisions and achieve strategic goals.
For any inquiries or to access the full report, please contact:
https://www.mordorintelligence.com/
Share on Social Media
Other Industry News
Ready to start publishing
Sign Up today!
